Scilife Pharma (Pvt.) Ltd. is proud to announce that our manufacturing facility has been approved by the Pharmaceutical Inspection Co-operation Scheme (PIC/S) member regulatory authority —one of the world’s most trusted benchmarks for Good Manufacturing Practices (GMP).

This certification, recognized across Europe, Africa, America, Asia, and Australasia, confirms that our medicines are produced under globally harmonized systems ensuring Quality, Efficacy, and Patient Safety.

For healthcare professionals and patients, this certification provides added confidence that Scilife medicines meet internationally accepted GMP standards, supporting reliable therapeutic outcomes and advancing patient care.